Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01745341 · ClinicalTrials.gov registry record

Rates of Apnea in Patients Undergoing Vitreoretinal Surgery

A clinical trial, sponsored by Stanford University.

Completed
Registry status
113
Enrollment target

NCT01745341: Completed study, sponsored by Stanford University.

NCT01745341 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01745341 has completed, sponsored by Stanford University.

COMPLETED
Registry status
113 participants
Enrollment target

Study Summary

The purpose of this study is to determine if apnea (the stopping of breathing) occurs in patients undergoing undergoing monitored anesthesia care (MAC) for vitreoretinal surgery

Primary Outcome

Determine if patients undergoing vitreoretinal surgery under monitored anesthesia care stop breathing during the procedure

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2012-08
Est. Completion 2013-08
Stanford University

1,744 total trials

What the finished NCT01745341 record still lists

NCT01745341 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01745341 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01745341 about?

NCT01745341 is a clinical study titled "Rates of Apnea in Patients Undergoing Vitreoretinal Surgery". The purpose of this study is to determine if apnea (the stopping of breathing) occurs in patients undergoing undergoing monitored anesthesia care (MAC) for vitreoretinal surgery

What is the current status of trial NCT01745341?

This trial is currently completed. The enrollment target is 113 participants. The study started on 2012-08. Estimated completion is 2013-08.

Who is sponsoring clinical trial NCT01745341?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01745341, the US trial registry maintained by the National Library of Medicine. NCT01745341 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.